243 related articles for article (PubMed ID: 37869238)
61. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
[TBL] [Abstract][Full Text] [Related]
62. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
[TBL] [Abstract][Full Text] [Related]
63. The immune escape mechanism of nasopharyngeal carcinoma.
Li X; Guo Y; Xiao M; Zhang W
FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482
[TBL] [Abstract][Full Text] [Related]
64. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.
Wu Q; You L; Nepovimova E; Heger Z; Wu W; Kuca K; Adam V
J Hematol Oncol; 2022 Jun; 15(1):77. PubMed ID: 35659268
[TBL] [Abstract][Full Text] [Related]
65. PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma.
Deng R; Lu J; Liu X; Peng XH; Wang J; Li XP
Cancer Manag Res; 2020; 12():11585-11596. PubMed ID: 33209062
[TBL] [Abstract][Full Text] [Related]
66. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.
Taeb S; Ashrafizadeh M; Zarrabi A; Rezapoor S; Musa AE; Farhood B; Najafi M
Curr Cancer Drug Targets; 2022; 22(1):18-30. PubMed ID: 34951575
[TBL] [Abstract][Full Text] [Related]
67. Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas.
Tamura R; Morimoto Y; Sato M; Kuranari Y; Oishi Y; Kosugi K; Yoshida K; Toda M
J Neurooncol; 2020 Jan; 146(2):265-273. PubMed ID: 31897926
[TBL] [Abstract][Full Text] [Related]
68. Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling.
Shi D; Guo W; Chen W; Fu L; Wang J; Tian Y; Xiao X; Kang T; Huang W; Deng W
PLoS One; 2012; 7(8):e43898. PubMed ID: 22952803
[TBL] [Abstract][Full Text] [Related]
69. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.
Lip H; Amini MA; Zetrini A; Cai P; Abbasi AZ; Bristow RG; Rauth AM; Wu XY
Radiother Oncol; 2022 May; 170():213-223. PubMed ID: 35227733
[TBL] [Abstract][Full Text] [Related]
70. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
[TBL] [Abstract][Full Text] [Related]
71. Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment.
Maeda-Otsuka S; Kajihara I; Tasaki Y; Yamada-Kanazawa S; Sakamoto R; Sawamura S; Masuzawa M; Masuzawa M; Amoh Y; Hoshina D; Abe R; Komohara Y; Ihn H
J Dermatol Sci; 2019 Feb; 93(2):123-132. PubMed ID: 30704938
[TBL] [Abstract][Full Text] [Related]
72. The role of hypoxia-inducible factor 1 in tumor immune evasion.
You L; Wu W; Wang X; Fang L; Adam V; Nepovimova E; Wu Q; Kuca K
Med Res Rev; 2021 May; 41(3):1622-1643. PubMed ID: 33305856
[TBL] [Abstract][Full Text] [Related]
73. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
74. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
[TBL] [Abstract][Full Text] [Related]
75. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Deng J; Li J; Sarde A; Lines JL; Lee YC; Qian DC; Pechenick DA; Manivanh R; Le Mercier I; Lowrey CH; Varn FS; Cheng C; Leib DA; Noelle RJ; Mabaera R
Cancer Immunol Res; 2019 Jul; 7(7):1079-1090. PubMed ID: 31088847
[TBL] [Abstract][Full Text] [Related]
76. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
77. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
78. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression.
Zhang C; Yang X; Zhang Q; Yang B; Xu L; Qin Q; Zhu H; Liu J; Cai J; Tao G; Ma J; Ge X; Zhang S; Cheng H; Sun X
Acta Otolaryngol; 2014 Feb; 134(2):185-92. PubMed ID: 24325635
[TBL] [Abstract][Full Text] [Related]
79. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
80. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]